- CH₣7.43bn
- CH₣8.54bn
- CH₣4.43bn
- 67
- 47
- 64
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 2,711 | 2,936 | 3,380 | 5,065 | 4,433 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,277 | 2,461 | 2,985 | 4,026 | 3,812 |
Operating Profit | 433 | 475 | 395 | 1,038 | 621 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 478 | 443 | 420 | 784 | 593 |
Provision for Income Taxes | |||||
Net Income After Taxes | 404 | 382 | 327 | 575 | 488 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 391 | 362 | 305 | 550 | 478 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 391 | 362 | 305 | 550 | 478 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.82 | 6.86 | 5.53 | 10.1 | 10.6 |
Dividends per Share |